SCHEMBL14633778

SCHEMBL14633778

Cc1ccccc1-n1nc(-c2cccc(N3CCCC3)n2)c2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WEE1 P30291 18/20 0.53
▸ PLK1 P53350 4/20 0.53
▸ CYP3A4 P08684 1/20 0.52
▸ LCK P06239 1/20 0.47
▸ LYN P07948 1/20 0.47
▸ KIT P10721 1/20 0.47
▸ SRC P12931 1/20 0.47
▸ BRAF P15056 1/20 0.47
▸ TYK2 P29597 1/20 0.47
▸ KDR P35968 1/20 0.47
▸ ZAP70 P43403 1/20 0.47
▸ SYK P43405 1/20 0.47
▸ JAK3 P52333 1/20 0.47
▸ MAPK10 P53779 1/20 0.47
▸ TEK Q02763 1/20 0.47
▸ BTK Q06187 1/20 0.47
▸ CCNK O75909 1/20 0.46
▸ CCNA2 P20248 1/20 0.46
▸ CDK2 P24941 1/20 0.46
▸ CCND3 P30281 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14633338 0.92 WEE1 (0.55) WEE1PLK1CYP3A4LCKSRC
SCHEMBL14633332 0.87 WEE1 (0.60) WEE1CYP3A4LCKSRCKDR
SCHEMBL14633043 0.86 JAK3 (0.56) WEE1PLK1CYP3A4LCKLYN
SCHEMBL14633311 0.85 WEE1 (0.53) WEE1PLK1CYP3A4LCKLYN
SCHEMBL14633585 0.84 WEE1 (0.54) WEE1PLK1CYP3A4LCKLYN
SCHEMBL14633257 0.84 WEE1 (0.53) WEE1PLK1CYP3A4LCKLYN
SCHEMBL14633397 0.83 WEE1 (0.53) WEE1PLK1CYP3A4LCKLYN
SCHEMBL14633297 0.82 WEE1 (0.52) WEE1PLK1CYP3A4LCKLYN
SCHEMBL14632968 0.82 WEE1 (0.58) WEE1PLK1CYP3A4LCKSRC
SCHEMBL14633135 0.82 WEE1 (0.56) WEE1PLK1CYP3A4LCKLYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US claimed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO claimed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US claimed
US-9051327-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2015-06-09 — — US disclosed
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBVIE INC (US) 2014-10-02 — — US disclosed
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US disclosed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO disclosed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885PLK1 93/4885CYP3A4 1925/4885
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885PLK1 93/4885CYP3A4 1925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback